Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Rivet, JM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 38 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dekeyne, A; Rivet, JM; Gobert, A; Millan, MJ
      Generalization of serotonin (5-HT)(1A) agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminativestimuli elicited by PD128,907 and 7-OH-DPAT

      NEUROPHARMACOLOGY
    2. Millan, MJ; Gobert, A; Lejeune, F; Newman-Tancredi, A; Rivet, JM; Auclair, A; Peglion, JL
      S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    3. Millan, MJ; Cussac, D; Milligan, G; Carr, C; Audinot, V; Gobert, A; Lejeune, F; Rivet, JM; Brocco, M; Duqueyroix, D; Nicolas, JP; Boutin, JA; Newman-Tancredi, A
      Antiparkinsonian agent piribedil displays antagonist properties at native,rat, and cloned, human alpha(2)-adrenoceptors: Cellular and functional characterization

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    4. Millan, MJ; Gobert, A; Rivet, JM; Adhumeau-Auclair, A; Cussac, D; Newman-Tancredi, A; Dekeyne, A; Nicolas, JP; Lejeune, F
      Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha(2)-adrenergic and serotonin(2C) receptors: a comparison with citalopram

      EUROPEAN JOURNAL OF NEUROSCIENCE
    5. Gobert, A; Rivet, JM; Lejeune, F; Newman-Tancredi, A; Adhumeau-Auclair, A; Nicolas, JP; Cistarelli, L; Melon, C; Millan, MJ
      Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat

      SYNAPSE
    6. Millan, MJ; Newman-Tancredi, A; Audinot, V; Cussac, D; Lejeune, F; Nicolas, JP; Coge, F; Galizzi, JP; Boutin, JA; Rivet, JM; Dekeyne, A; Gobert, A
      Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT1B, 5-HT1D and dopamine D-2 and D-3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states

      SYNAPSE
    7. Millan, MJ; Lejeune, F; Gobert, A; Brocco, M; Auclair, A; Bosc, C; Rivet, JM; Lacoste, JM; Cordi, A; Dekeyne, A
      S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    8. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Dubuffet, T; Lavielle, G
      S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    9. Millan, MJ; Dekeyne, A; Rivet, JM; Dubuffet, T; Lavielle, G; Brocco, M
      S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    10. Millan, MJ; Gobert, A; Bervoets, K; Rivet, JM; Veiga, S; Brocco, M
      Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: Roles of multiple monoaminergic receptorsin relation to the actions of antipsychotic agents

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    11. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Adhumeau, A; Brocco, M; Nicolas, JP; Boutin, JA; Despaux, N; Peglion, JL
      S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    12. Millan, MJ; Brocco, M; Rivet, JM; Audinot, V; Newman-Tancredi, A; Maiofiss, L; Queriaux, S; Despaux, N; Peglion, JL; Dekeyne, A
      S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine,and 11 other antipsychotic agents

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    13. Millan, MJ; Brocco, M; Gobert, A; Joly, F; Bervoets, K; Rivet, JM; Newman-Tancredi, A; Audinot, V; Maurel, S
      Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat

      EUROPEAN JOURNAL OF NEUROSCIENCE
    14. Gobert, A; Rivet, JM; Cistarelli, L; Melon, C; Millan, MJ
      Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: Activation of serotonin(1A) receptors and blockade of alpha(2)-adrenergic receptors underlie its actions

      NEUROSCIENCE
    15. Newman-Tancredi, A; Rivet, JM; Chaput, C; Touzard, M; Verriele, L; Millan, MJ
      The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [S-35]GTP gamma S and [H-3]S15535 autoradiography study

      EUROPEAN JOURNAL OF PHARMACOLOGY
    16. GOBERT A; RIVET JM; AUDINOT V; NEWMANTANCREDI A; CISTARELLI L; MILLAN MJ
      SIMULTANEOUS QUANTIFICATION OF SEROTONIN, DOPAMINE AND NORADRENALINE LEVELS IN SINGLE FRONTAL-CORTEX DIALYSATES OF FREELY-MOVING RATS REVEALS A COMPLEX PATTERN OF RECIPROCAL AUTO-MEDIATED AND HETERORECEPTOR-MEDIATED CONTROL OF RELEASE

      Neuroscience
    17. MILLAN MJ; NEWMANTANCREDI A; BROCCO N; GOBERT A; LEJEUNE F; AUDINOT V; RIVET JM; SCHREIBER R; DEKEYNE A; SPEDDING M; NICOLAS JP; PEGLION JL
      S-18126 4-(2,3-DIHYDROBENZO[1,4]DIOXIN-6-YL)PIPERAZIN-1-YL METHYL]INDAN-2-YL)), A POTENT, SELECTIVE AND COMPETITIVE ANTAGONIST AT DOPAMINE D-4 RECEPTORS - AN IN-VITRO AND IN-VIVO COMPARISON WITH L-745,870 YL]PIPERAZIN-1-YL)METHYL-1H-PYRROLO[2,3B]PYRIDINE) AND RACLOPRIDE

      The Journal of pharmacology and experimental therapeutics
    18. AUDINOT V; NEWMANTANCREDI A; GOBERT A; RIVET JM; BROCCO M; LEJEUNE F; GLUCK L; DESPOSTE I; BERVOETS K; DEKEYNE A; MILLAN MJ
      A COMPARATIVE IN-VITRO AND IN-VIVO PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL DOPAMINE D-3 RECEPTOR ANTAGONISTS (-S-14297, NAFADOTRIDE, GR-103,691 AND U-99194())

      The Journal of pharmacology and experimental therapeutics
    19. MILLAN MJ; GOBERT A; NEWMANTANCREDI A; AUDINOT V; LEJEUNE F; RIVET JM; CUSSAC D; NICOLAS JP; MULLER O; LAVIELLE G
      S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - I - RECEPTORIAL AND NEUROCHEMICAL PROFILE COMPARISON WITH CLOZAPINE AND HALOPERIDOL

      The Journal of pharmacology and experimental therapeutics
    20. MILLAN MJ; SCHREIBER R; DEKEYNE A; RIVET JM; BERVOETS K; MAVRIDIS M; SEBBAN C; MAURELREMY S; NEWMANTANCREDI A; SPEDDING M; MULLER O; LAVIELLE G; BROCCO M
      S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL, POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - II - FUNCTIONAL PROFILE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL

      The Journal of pharmacology and experimental therapeutics
    21. MILLAN MJ; NEWMANTANCREDI A; RIVET JM; BROCCO M; LACROIX P; AUDINOT V; CISTARELLI L; GOBERT A
      S-15535, A NOVEL BENZODIOXOPIPERAZINE LIGAND OF SEROTONIN (5-HT)(1A) RECEPTORS .1. INTERACTION WITH CLONED HUMAN (H)5-HT1A, DOPAMINE HD(2) HD(3) AND H-ALPHA(2A)-ADRENERGIC RECEPTORS IN RELATION TO MODULATION OF CORTICAL MONOAMINE RELEASE AND ACTIVITY IN MODELS OF POTENTIAL ANTIDEPRESSANT ACTIVITY/

      The Journal of pharmacology and experimental therapeutics
    22. GOBERT A; RIVET JM; CISTARELLI L; MELON C; MILLAN MJ
      ALPHA(2)-ADRENERGIC RECEPTOR BLOCKADE MARKEDLY POTENTIATES DULOXETINE-INDUCED AND FLUOXETINE-INDUCED INCREASES IN NORADRENALINE, DOPAMINE, AND SEROTONIN LEVELS IN THE FRONTAL-CORTEX OF FREELY MOVING RATS

      Journal of neurochemistry
    23. GOBERT A; RIVET JM; CISTARELLI L; MILLAN MJ
      POTENTIATION OF THE FLUOXETINE-INDUCED INCREASE IN DIALYSATE LEVELS OF SEROTONIN (5-HT) IN THE FRONTAL-CORTEX OF FREELY MOVING RATS BY COMBINED BLOCKADE OF 5-HT1A AND 5-HT1B RECEPTORS WITH WAY-100,635 AND GR-127,935

      Journal of neurochemistry
    24. GOBERT A; RIVET JM; CISTARELLI L; MILLAN MJ
      BUSPIRONE ENHANCES DULOXETINE-INDUCED AND FLUOXETINE-INDUCED INCREASES IN DIALYSATE LEVELS OF DOPAMINE AND NORADRENALINE, BUT NOT SEROTONIN, IN THE FRONTAL-CORTEX OF FREELY MOVING RATS

      Journal of neurochemistry
    25. GOBERT A; LEJEUNE F; RIVET JM; CISTARELLI L; MILLAN MJ
      DOPAMINE D-3 (AUTO) RECEPTORS INHIBIT DOPAMINE RELEASE IN THE FRONTAL-CORTEX OF FREELY MOVING RATS IN-VIVO

      Journal of neurochemistry
    26. MILLAN MJ; PEGLION JL; VIAN J; RIVET JM; BROCCO M; GOBERT A; NEWMANTANCREDI A; DACQUET C; BERVOETS K; GIRARDON S; JACQUES V; CHAPUT C; AUDINOT V
      FUNCTIONAL CORRELATES OF DOPAMINE D-3 RECEPTOR ACTIVATION IN THE RAT IN-VIVO AND THEIR MODULATION BY THE SELECTIVE ANTAGONIST, (-S-14297 .1. ACTIVATION OF POSTSYNAPTIC D-3, RECEPTORS MEDIATES HYPOTHERMIA, WHEREAS BLOCKADE OF D-2 RECEPTORS ELICITS PROLACTIN SECRETION AND CATALEPSY())

      The Journal of pharmacology and experimental therapeutics
    27. GOBERT A; RIVET JM; AUDINOT V; CISTARELLI L; SPEDDING M; VIAN J; PEGLION JL; MILLAN MJ
      FUNCTIONAL CORRELATES OF DOPAMINE D-3, RECEPTOR ACTIVATION IN THE RATIN-VIVO AND THEIR MODULATION BY THE SELECTIVE ANTAGONIST, (-S-14297 .2. BOTH D-2 AND SILENT D-3 AUTORECEPTORS CONTROL SYNTHESIS AND RELEASEIN MESOLIMBIC, MESOCORTICAL AND NIGROSTRIATAL PATHWAYS())

      The Journal of pharmacology and experimental therapeutics
    28. GOBERT A; LEJEUNE F; RIVET JM; AUDINOT V; NEWMANTANCREDI A; MILLAN MJ
      MODULATION OF THE ACTIVITY OF CENTRAL SEROTONINERGIC NEURONS BY NOVELSEROTONIN(1A) RECEPTOR AGONISTS AND ANTAGONISTS - A COMPARISON TO ADRENERGIC AND DOPAMINERGIC-NEURONS IN RATS

      The Journal of pharmacology and experimental therapeutics
    29. MILLAN MJ; RIVET JM; AUDINOT V; GOBERT A; LEJEUNE F; BROCCO M; NEWMANTANCREDI A; MAURELREMY S; BERVOETS K
      ANTAGONIST PROPERTIES OF LY-165,163 AT PRESYNAPTIC AND POSTSYNAPTIC DOPAMINE D-2, D-3, AND D-1 RECEPTORS - MODULATION OF AGONIST ACTIONS AT5-HT1A RECEPTORS IN-VIVO

      The Journal of pharmacology and experimental therapeutics
    30. MILLAN MJ; BERVOETS K; RIVET JM; WIDDOWSON P; RENOUARD A; LEMAROUILLEGIRARDON S; GOBERT A
      MULTIPLE ALPHA-2-ADRENERGIC RECEPTOR SUBTYPES .2. EVIDENCE FOR A ROLEOF RAT R(ALPHA-2A), ADRENERGIC-RECEPTORS IN THE CONTROL OF NOCICEPTION, MOTOR BEHAVIOR AND HIPPOCAMPAL SYNTHESIS OF NORADRENALINE

      The Journal of pharmacology and experimental therapeutics
    31. MILLAN MJ; RIVET JM; GOBERT A; CANTON H; VEIGA S; BERVOETS K
      5-HT1A RECEPTORS AND THE TAIL-FLICK RESPONSE .6. INTRINSIC ALPHA(1A)-ADRENOCEPTOR ANTAGONIST PROPERTIES CAN MASK THE ACTIONS OF 5-HT1A RECEPTOR AGONISTS IN THE SPONTANEOUS TAIL-FLICK PARADIGM

      The Journal of pharmacology and experimental therapeutics
    32. MILLAN MJ; CANTON H; GOBERT A; LEJEUNE F; RIVET JM; BERVOETS K; BROCCO M; WIDDOWSON P; MENNINI T; AUDINOT V; HONORE P; RENOUARD A; LEMAROUILLEGIRARDON S; VERRIELE L; GRESSIER H; PEGLION JL
      NOVEL BENZODIOXOPIPERAZINES ACTING AS ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS AND AS AGONISTS AT 5-HT1A AUTORECEPTORS - A COMPARATIVE PHARMACOLOGICAL CHARACTERIZATION WITH PROPOSED 5-HT1A ANTAGONISTS

      The Journal of pharmacology and experimental therapeutics
    33. RIVET JM; AUDINOT V; GOBERT A; PEGLION JL; MILLAN MJ
      MODULATION OF MESOLIMBIC DOPAMINE RELEASE BY THE SELECTIVE DOPAMINE-D-3 RECEPTOR ANTAGONIST, (-S-14297())

      European journal of pharmacology
    34. MILLAN MJ; AUDINOT V; RIVET JM; GOBERT A; VIAN J; PROST JF; SPEDDING M; PEGLION JL
      S-14297, A NOVEL SELECTIVE LIGAND AT CLONED HUMAN DOPAMINE-D-3 RECEPTORS, BLOCKS 7-OH-DPAT-INDUCED HYPOTHERMIA IN RATS

      European journal of pharmacology
    35. LEJEUNE F; AUDINOT V; GOBERT A; RIVET JM; SPEDDING M; MILLAN MJ
      CLOZAPINE INHIBITS SEROTONINERGIC TRANSMISSION BY AN ACTION AT ALPHA(1)-ADRENOCEPTORS NOT AT 5-HT1A RECEPTORS

      European journal of pharmacology
    36. LEJEUNE F; GOBERT A; RIVET JM; MILLAN MJ
      BLOCKADE OF TRANSMISSION AT NMDA RECEPTORS FACILITATES THE ELECTRICALAND SYNTHETIC ACTIVITY OF ASCENDING SEROTONINERGIC NEURONS

      Brain research
    37. GOBERT A; WIDDOWSON P; RENOUARD A; RIVET JM; BERVOETS K; MILLAN MJ
      MULTIPLE ALPHA2-ADRENOCEPTOR SUBTYPES - AN EXAMINATION OF THE SUBTYPEMODULATING NORADRENALINE SYNTHESIS IN RAT HIPPOCAMPUS

      Journal of neurochemistry
    38. LEJEUNE F; RIVET JM; GOBERT A; CANTON H; MILLAN MJ
      WAY-100,135 AND (-)-TERTATOLOL ACT AS ANTAGONISTS AT BOTH 5-HT(1A) AUTORECEPTORS AND POSTSYNAPTIC 5-HT(1A) RECEPTORS IN-VIVO

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 12:58:22